Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RPRXD

Repros Therapeutics Inc. (MM) (RPRXD)

Repros Therapeutics Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RPRXD
DateTimeSourceHeadlineSymbolCompany
11/11/201004:27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
10/11/201005:29Business WireRepros® Therapeutics Reports Outcome of Type B Meeting with FDA Regarding Androxal® in the Treatment of Secondary HypogonadismNASDAQ:RPRXDRepros Therapeutics Inc. (MM)
02/11/201003:27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
30/10/201008:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
30/10/201008:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
30/10/201008:04Business WireRepros® Has Regained Compliance with Nasdaq Continued Listing RequirementsNASDAQ:RPRXDRepros Therapeutics Inc. (MM)
26/10/201004:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
26/10/201001:36Business WireRepros® Therapeutics Begins Randomization of Subjects in Androxal® Type II Diabetes Phase II TrialNASDAQ:RPRXDRepros Therapeutics Inc. (MM)
16/10/201008:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
16/10/201001:53Edgar (US Regulatory)Current report filing (8-K)NASDAQ:RPRXDRepros Therapeutics Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:RPRXD